FB Bancorp (FBLA) discloses director award of restricted stock and options
Rhea-AI Filing Summary
FB Bancorp, Inc. reported that one of its directors received new equity awards in the company’s common stock on December 10, 2025. The director was granted 29,756 shares of restricted stock at a reported price of $0, which will vest in installments of 20% per year starting on December 10, 2026.
On the same date, the director was also granted 74,390 stock options with an exercise price of $13.16 per share, vesting 20% per year beginning December 10, 2026 and expiring on December 10, 2035. Following these grants, the reporting person beneficially owns 45,756 common shares directly, 4,000 shares indirectly through an IRA, and 74,390 stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options | 0 | $0.00 | -- |
| Grant/Award | Common Stock | 29,756 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Shares of restricted stock vest at a rate of 20% per year commencing on December 10, 2026. Stock options vest at a rate of 20% per year commencing on December 10, 2026.
FAQ
What insider equity awards did FB Bancorp (FBLA) disclose for its director?
FB Bancorp, Inc. disclosed that a director received 29,756 shares of restricted common stock at a reported price of $0 and a grant of 74,390 stock options with an exercise price of $13.16 per share on December 10, 2025.
What are the key terms of the FB Bancorp (FBLA) stock options granted to the director?
The director received 74,390 stock options with an exercise price of $13.16 per share. These options become exercisable as they vest 20% per year starting on December 10, 2026 and have an expiration date of December 10, 2035.
Did the FB Bancorp director pay a purchase price for the restricted stock or stock options?
The restricted stock grant of 29,756 shares was reported with a price of $0. The stock options were also reported with a price of $0 for the grant itself, but they carry an exercise price of $13.16 per share if exercised.